# clm_14B748327E60

subject: Abbott Laboratories (/record/abbott-laboratories.md)  
predicate: cash_and_equivalents  
value: 9,161,000,000 United States dollar  
valid_from: 2023-03-31  
valid_to: 2023-06-30  
published: 2023-05-04  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_34B14167D6F5  
last_updated: 2026-11-08  
cite: AsOf. "Abbott Laboratories cash and equivalents: 9,161,000,000 United States dollar", as of 2023-03-31 (until 2023-06-30). Claim clm_14B748327E60, https://asof.is/claim/clm_14B748327E60, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-04  

## Sources

- https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm (primary, SEC EDGAR 10-Q Q1 FY2023, published 2023-05-04)

## Supersedes

- [Abbott Laboratories](/record/abbott-laboratories.md) | cash_and_equivalents | 9,882,000,000 United States dollar | valid 2022-12-31 to 2023-03-31 | conf 0.95 | superseded | superseded_by [clm_14B748327E60](/claim/clm_14B748327E60.md) | [clm_B5EA4556B88D](/claim/clm_B5EA4556B88D.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.